Cite
In vitro evaluation of CRISPR PX-LmGP63 vector effect on pathogenicity of Leishmania major as a primary step to control leishmaniasis.
MLA
Ebrahimi, Saeedeh, et al. “In Vitro Evaluation of CRISPR PX-LmGP63 Vector Effect on Pathogenicity of Leishmania Major as a Primary Step to Control Leishmaniasis.” Microbial Pathogenesis, vol. 161, Dec. 2021, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.micpath.2021.105281.
APA
Ebrahimi, S., Kalantari, M., Alipour, H., Azizi, K., Asgari, Q., & Bahreini, M. S. (2021). In vitro evaluation of CRISPR PX-LmGP63 vector effect on pathogenicity of Leishmania major as a primary step to control leishmaniasis. Microbial Pathogenesis, 161, N.PAG. https://doi.org/10.1016/j.micpath.2021.105281
Chicago
Ebrahimi, Saeedeh, Mohsen Kalantari, Hamzeh Alipour, Kourosh Azizi, Qasem Asgari, and Mohammad Saleh Bahreini. 2021. “In Vitro Evaluation of CRISPR PX-LmGP63 Vector Effect on Pathogenicity of Leishmania Major as a Primary Step to Control Leishmaniasis.” Microbial Pathogenesis 161 (December): N.PAG. doi:10.1016/j.micpath.2021.105281.